Blog

Majority of pharmaceutical companies are persisting with decade old processes and routines.  They have transactional relationships with suppliers, lack of concerted efforts to progress ahead, and no vision to reap productivity rewards.  The reasons for continuing with these traditional practices include tax regimes, regulatory hurdles, and stable revenues from customers dependent on existing industry offerings.

Disruption—spurred by technological Innovation, fluctuating customer demand patterns,

Large accounts make up a significant portion of business for most B2B companies. Therefore, losing an important customer can have detrimental effects on the organization. The significance of key accounts is urging top B2B companies to revisit their key account management approaches. Additionally, the increasing level of sophistication of the purchase process being adopted—such as, centralized procurement, competitive bidding and auctions, and laborious negotiations—by large buyers is a crucial

The 7th Edition Third Party Vendor Risk Management for Financial Institutions Conference will bring together leaders involved in vendor risk management, procurement, data security, and contract management to apply practical strategies to evolve your current third party oversight program. Learn best practices in managerial strategy from industry leaders to streamline third parties with your business goals, ensuring the development of holistic governance strategies. Furthermore, maximize your due